Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - cladribine - tablet - cladribine 10mg

European Union - English - EMA (European Medicines Agency)

merck europe b.v. - cladribine - multiple sclerosis - immunosuppressants - treatment of adult patients with highly active relapsing multiple sclerosis (ms) as defined by clinical or imaging features.

Canada - English - Health Canada

emd serono, a division of emd inc., canada - cladribine - tablet - 10mg - cladribine 10mg - immunosuppressive agents

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الادوية العربي - the arab drug store p.s.c - cladribine 10 mg - 10 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - cladribine 10mg;   - tablet - 10 mg - active: cladribine 10mg   excipient: hydroxypropyl-beta-cyclodextrin magnesium stearate sorbitol water for injection - mavenclad is indicated for the treatment of relapsing-remitting multiple sclerosis (rrms) to reduce the frequency of clinical relapses and to delay the progression of physical disability. following completion of the two treatment courses, no further cladribine treatment is required in years three and four. re-initiation of therapy after year four has not been studied.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - cladribine 10mg;   - tablet - 10 mg - active: cladribine 10mg   excipient: hydroxypropyl-beta-cyclodextrin magnesium stearate sorbitol water for injection - mavenclad is indicated for the treatment of relapsing-remitting multiple sclerosis (rrms) to reduce the frequency of clinical relapses and to delay the progression of physical disability. following completion of the two treatment courses, no further cladribine treatment is required in years three and four. re-initiation of therapy after year four has not been studied.

Israel - English - Ministry of Health

merck serono ltd - cladribine - tablets - cladribine 10 mg - cladribine - mavenclad 10mg tablets is indicated for the treatment of adult patients with highly active relapsing multiple sclerosis (ms) as defined by clinical or imaging features

Israel - English - Ministry of Health

merck serono ltd - cladribine - tablets - cladribine 10 mg - cladribine - mavenclad 10mg tablets is indicated for the treatment of adult patients with highly active relapsing multiple sclerosis (ms) as defined by clinical or imaging features

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sdn. bhd. - cladribine -